Qinqin Wang, Lingjun Liu, Qiao Zhang, Hong Li, Qianli Ma
{"title":"六份COPD问卷的动态表现和基于场景的筛选策略:一项具有患病率驱动的稳健性验证的横断面研究。","authors":"Qinqin Wang, Lingjun Liu, Qiao Zhang, Hong Li, Qianli Ma","doi":"10.3389/fmed.2025.1666703","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Chronic Obstructive Pulmonary Disease (COPD) imposes a high global burden. Spirometry is the diagnostic gold standard but has accessibility barriers. Screening questionnaires provide a feasible alternative.</p><p><strong>Objectives: </strong>To compare the diagnostic performance and robustness of six COPD screening questionnaires (LFQ: Lung Function Questionnaire; IPAG: International Primary Care Airways Group Questionnaire; Modified-IPAG; COPD-PS: COPD Population Screener Questionnaire; COPD-SQ: COPD Screening Questionnaire; SCSQ: The Salzburg COPD Screening Questionnaire) within a single cohort population, thereby providing evidence to support targeted screening for COPD.</p><p><strong>Methods: </strong>This cross-sectional study enrolled adults ≥40 years without prior asthma or non-COPD chronic lung diseases. Participants completed six screening questionnaires and spirometry. COPD was confirmed by pulmonologists. Receiver operating characteristic (ROC) curves were constructed for each questionnaire; sensitivity, specificity, accuracy (ACC), positive predictive value (PPV), negative predictive value (NPV), and area under the curve (AUC) were calculated. Dynamic variations in screening performance were simulated under different disease prevalence scenarios.</p><p><strong>Results: </strong>Modified-IPAG and LFQ showed highest sensitivity (94.78%/91.79%) and NPV (98.11%/97.45%); COPD-PS and COPD-SQ had highest specificity (79.32%/87.05%) and PPV (43.50%/43.87%). AUC ranged 0.681 (SCSQ)-0.796 (COPD-PS). Dynamic simulations revealed COPD-PS maintained stable ACC across prevalence (ΔACC = 0.06; β = -0.018; <i>P</i> = 0.114), while SQ declined with increasing prevalence (ΔACC = 0.26; β = -0.263; <i>P</i> < 0.001).</p><p><strong>Conclusion: </strong>A \"Scenario-Priority\" strategy is proposed: For rule-out screening, use high-sensitivity tools (Modified-IPAG/LFQ); for high-risk identification, prioritize robust COPD-PS; in low-prevalence regions (<30%), use high-specificity SQ. This approach transcends the conventional \"tool-first\" static framework, delivering evidence-based support for precision COPD screening implementation.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"12 ","pages":"1666703"},"PeriodicalIF":3.1000,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12504273/pdf/","citationCount":"0","resultStr":"{\"title\":\"Dynamic performance and scenario-based screening strategy of six COPD questionnaires: a cross-sectional study with prevalence-driven robustness validation.\",\"authors\":\"Qinqin Wang, Lingjun Liu, Qiao Zhang, Hong Li, Qianli Ma\",\"doi\":\"10.3389/fmed.2025.1666703\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Chronic Obstructive Pulmonary Disease (COPD) imposes a high global burden. Spirometry is the diagnostic gold standard but has accessibility barriers. Screening questionnaires provide a feasible alternative.</p><p><strong>Objectives: </strong>To compare the diagnostic performance and robustness of six COPD screening questionnaires (LFQ: Lung Function Questionnaire; IPAG: International Primary Care Airways Group Questionnaire; Modified-IPAG; COPD-PS: COPD Population Screener Questionnaire; COPD-SQ: COPD Screening Questionnaire; SCSQ: The Salzburg COPD Screening Questionnaire) within a single cohort population, thereby providing evidence to support targeted screening for COPD.</p><p><strong>Methods: </strong>This cross-sectional study enrolled adults ≥40 years without prior asthma or non-COPD chronic lung diseases. Participants completed six screening questionnaires and spirometry. COPD was confirmed by pulmonologists. Receiver operating characteristic (ROC) curves were constructed for each questionnaire; sensitivity, specificity, accuracy (ACC), positive predictive value (PPV), negative predictive value (NPV), and area under the curve (AUC) were calculated. Dynamic variations in screening performance were simulated under different disease prevalence scenarios.</p><p><strong>Results: </strong>Modified-IPAG and LFQ showed highest sensitivity (94.78%/91.79%) and NPV (98.11%/97.45%); COPD-PS and COPD-SQ had highest specificity (79.32%/87.05%) and PPV (43.50%/43.87%). AUC ranged 0.681 (SCSQ)-0.796 (COPD-PS). Dynamic simulations revealed COPD-PS maintained stable ACC across prevalence (ΔACC = 0.06; β = -0.018; <i>P</i> = 0.114), while SQ declined with increasing prevalence (ΔACC = 0.26; β = -0.263; <i>P</i> < 0.001).</p><p><strong>Conclusion: </strong>A \\\"Scenario-Priority\\\" strategy is proposed: For rule-out screening, use high-sensitivity tools (Modified-IPAG/LFQ); for high-risk identification, prioritize robust COPD-PS; in low-prevalence regions (<30%), use high-specificity SQ. This approach transcends the conventional \\\"tool-first\\\" static framework, delivering evidence-based support for precision COPD screening implementation.</p>\",\"PeriodicalId\":12488,\"journal\":{\"name\":\"Frontiers in Medicine\",\"volume\":\"12 \",\"pages\":\"1666703\"},\"PeriodicalIF\":3.1000,\"publicationDate\":\"2025-09-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12504273/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3389/fmed.2025.1666703\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fmed.2025.1666703","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
Dynamic performance and scenario-based screening strategy of six COPD questionnaires: a cross-sectional study with prevalence-driven robustness validation.
Introduction: Chronic Obstructive Pulmonary Disease (COPD) imposes a high global burden. Spirometry is the diagnostic gold standard but has accessibility barriers. Screening questionnaires provide a feasible alternative.
Objectives: To compare the diagnostic performance and robustness of six COPD screening questionnaires (LFQ: Lung Function Questionnaire; IPAG: International Primary Care Airways Group Questionnaire; Modified-IPAG; COPD-PS: COPD Population Screener Questionnaire; COPD-SQ: COPD Screening Questionnaire; SCSQ: The Salzburg COPD Screening Questionnaire) within a single cohort population, thereby providing evidence to support targeted screening for COPD.
Methods: This cross-sectional study enrolled adults ≥40 years without prior asthma or non-COPD chronic lung diseases. Participants completed six screening questionnaires and spirometry. COPD was confirmed by pulmonologists. Receiver operating characteristic (ROC) curves were constructed for each questionnaire; sensitivity, specificity, accuracy (ACC), positive predictive value (PPV), negative predictive value (NPV), and area under the curve (AUC) were calculated. Dynamic variations in screening performance were simulated under different disease prevalence scenarios.
Results: Modified-IPAG and LFQ showed highest sensitivity (94.78%/91.79%) and NPV (98.11%/97.45%); COPD-PS and COPD-SQ had highest specificity (79.32%/87.05%) and PPV (43.50%/43.87%). AUC ranged 0.681 (SCSQ)-0.796 (COPD-PS). Dynamic simulations revealed COPD-PS maintained stable ACC across prevalence (ΔACC = 0.06; β = -0.018; P = 0.114), while SQ declined with increasing prevalence (ΔACC = 0.26; β = -0.263; P < 0.001).
Conclusion: A "Scenario-Priority" strategy is proposed: For rule-out screening, use high-sensitivity tools (Modified-IPAG/LFQ); for high-risk identification, prioritize robust COPD-PS; in low-prevalence regions (<30%), use high-specificity SQ. This approach transcends the conventional "tool-first" static framework, delivering evidence-based support for precision COPD screening implementation.
期刊介绍:
Frontiers in Medicine publishes rigorously peer-reviewed research linking basic research to clinical practice and patient care, as well as translating scientific advances into new therapies and diagnostic tools. Led by an outstanding Editorial Board of international experts, this multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
In addition to papers that provide a link between basic research and clinical practice, a particular emphasis is given to studies that are directly relevant to patient care. In this spirit, the journal publishes the latest research results and medical knowledge that facilitate the translation of scientific advances into new therapies or diagnostic tools. The full listing of the Specialty Sections represented by Frontiers in Medicine is as listed below. As well as the established medical disciplines, Frontiers in Medicine is launching new sections that together will facilitate
- the use of patient-reported outcomes under real world conditions
- the exploitation of big data and the use of novel information and communication tools in the assessment of new medicines
- the scientific bases for guidelines and decisions from regulatory authorities
- access to medicinal products and medical devices worldwide
- addressing the grand health challenges around the world